Cannabis Law Report

JUNE 2, 2021

Samples will be collected via anterior nasal swabs that offer ease-of-use for all ages. Key end-markets include Gov/Mil, textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. Pooled surveillance testing of all campers will be conducted prior to the start of each of two summer sessions and once on-site.

Clinical Trials 82

Clinical Trials Therapy Research and Development Collective 82

Cannabis Law Report

JANUARY 18, 2022

ADCL’s safeCircle program is a fully integrated testing platform for enterprise and educational institutions that provides a full range of COVID-19 diagnostic testing and associated services, including sample collection, test site infrastructure design and management, results tracking, and vaccination status management. Dr. James A.

Research and Development 52

Research and Development Therapy Supply Chain Collective 52

Cannabis Law Report

JULY 28, 2021

Additionally, as previously announced on January 21, 2021, Unifor and Aleafia entered into an exclusive 10-year agreement to support union members, retirees and their eligible dependents that receive medical cannabis insurance coverage clinics through Unifor’s collective bargaining agreements. The recent addition of KGK Science Inc.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

Cannabis Law Report

JANUARY 4, 2022

Assay and Recently Developed, Unsupervised, At-Home Sample Collection Kit to Expand Addressable Market and Scope of COVID-19 Testing Services – STONY BROOK, N.Y.–(BUSINESS Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. Assay (the “Linea 2.0

Conditions 52

Conditions Research and Development Therapy Supply Chain 52

Cannabis Law Report

OCTOBER 25, 2021

The test is also intended for use with anterior nasal swab specimens that are self-collected in the presence of an HCP from individuals without symptoms or other reasons to suspect COVID-19 when tested at least weekly and with no more than 168 hours between serially collected specimens. Visit adnas.com for more information.

Research and Development 52

Research and Development Therapy Collective Treatment 52

Cannabis Law Report

OCTOBER 12, 2021

Mary Hartnett, Director of Medical Services at Sarah Lawrence College, stated, “safeCircle was our choice given the convenience of its on-site sample collection process, access to high-sensitivity RT-PCR-based testing with rapid turnaround times, ability to scale with our needs, and capacity to ease our administrative burdens.

Programs 52

Programs Clinical Trials Research and Development Therapy 52

Cannabis Law Report

SEPTEMBER 8, 2021

Products will be distributed through Valens’ Australian Distribution Partner, Cannvalate PTY Ltd (“Cannvalate”), and will be the largest quantity of products provided to Cannvalate for distribution to date (collectively, the “ Transaction “). Discover more on The Valens Company and its subsidiaries at [link]. regulatory risk, U.S.

Access 97

Access Research and Development Medicine THC 97

Cannabis Law Report

NOVEMBER 5, 2021

Sample collection for weekly COVID-19 pooled testing can be performed in-person (supervised) or via self-collection kits 1. 1 Availability of self-collection kits is subject to pending regulatory approval. Key end-markets include Gov/Mil, textiles, pharmaceuticals and nutraceuticals, and cannabis, among others.

Compliance 52

Compliance Compliance Research and Development Therapy 52

Cannabis Law Report

OCTOBER 6, 2021

With its population of almost 70 million and its history of using cannabinoid-based medicines, Thailand could quickly become one of the world’s largest medical cannabis markets. MPXI, SIM and Salus Thailand have assembled a strong management and advisory team that will collectively contribute to the success of this enterprise.” (See

Extraction 52

Extraction Research and Development Cultivation Events 52

SMPL

MAY 26, 2020

We were talking about, ‘What can we do with this?’ ” recalled Samantha Miller, who hosted the event at her split-level house, wedged between redwoods and a creek below. And because CBD doesn’t get you high, it was easy to miss; hardly anyone outside of pharmaceutical companies and academia had heard of it.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

SpeedWeed

JULY 17, 2021

He also credits cannabis for saving his life from suicide, a side effect of the heavy pharmaceuticals he was prescribed. In other words, athletes can’t use cannabis on the day of their event. . The science speaks to [cannabis] putting the human body into homeostasis, which is another word for balance. All of this is abhorrent.

THC 52

THC Cannabinoids History Events 52

Cannabis Law Report

OCTOBER 26, 2019

doctors, dentists, radiographers, nurses, pharmacists and psychologists) for patients who do not fit the Category A definition and where the UTG is not deemed to have an ‘established history of use’ Approval from the TGA is required before the UTG may be accessed. Adverse event reports are published online.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

NOVEMBER 24, 2021

The Cannabis sativa plant has an incredibly multi-layered, rich, and versatile history of human uses for food and fibre, as well as recreational, and religious and spiritual purposes throughout the world (McPartland and Hegman 2018 ; Aldrich 1997 ; Touw 1981 ; Li 1974 ; Bonini et al. Data collection. 2018 ; Frankhauser 2008 ).

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 4, 2021

Rick has appeared on countless media outlets and has been a speaker at dozens of major events, resulting in MAPS raising tens of millions of dollars to further develop the future of psychedelic studies. Brian Muraresku is the New York Times Bestselling author of The Immortality Key: The Secret History of the Religion with No Name.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51